Journal of cancer immunology最新文献

筛选
英文 中文
Quantifying Neural Stem Cell-Derived Extracellular Vesicle Uptake Using Imaging Flow Cytometry 用成像流式细胞术定量神经干细胞来源的细胞外小泡摄取
Journal of cancer immunology Pub Date : 2021-11-05 DOI: 10.33696/cancerimmunol.3.049
Taylor J. Ellison, B. Jurgielewicz, S. Stice, Yao Yao
{"title":"Quantifying Neural Stem Cell-Derived Extracellular Vesicle Uptake Using Imaging Flow Cytometry","authors":"Taylor J. Ellison, B. Jurgielewicz, S. Stice, Yao Yao","doi":"10.33696/cancerimmunol.3.049","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.049","url":null,"abstract":"Nanomedicine, which includes nanoparticles and other nanomaterials for diagnosis and therapeutic delivery to treat numerous diseases, is making advances [1]. Utilizing engineered nanomaterials as delivery shuttles for therapeutics provides an opportunity to increase targeting specificity for treatments of certain disorders, as well as provide intrinsic benefits to cell systems of interest [2,3]. However, it is important to understand the functional properties of materials in pre-clinical studies. Proper selection of nanomaterials could be enhanced by recent studies in the field of cellular uptake of nanomaterials. The study of EVs is an expanding field within nanomedicine and are one such example of nanomaterials as a drug delivery shuttle. EVs are lipid-bound vesicles ranging in size from 40-1000 nm that mediate intercellular communication through shuttling nucleic acids, protein and lipids between cells. Once thought to be the secreted waste of cells, EVs have been engineered as drug delivery vectors due to multiple intrinsic benefits such as biocompatibility of genetic materials, therapeutic potentials, low immunogenicity and toxicity, ability to cross bio-barriers and for repeated dosing, various routes of administration [4-6]. Previous work from our group and others indicates that the therapeutic potential and Abstract","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44974744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-PD1 Therapy in Lynch Syndrome-associated Recurrent Glioblastoma 抗pd1治疗Lynch综合征相关复发性胶质母细胞瘤
Journal of cancer immunology Pub Date : 2021-11-05 DOI: 10.33696/cancerimmunol.3.051
Wendy J. Sherman
{"title":"Anti-PD1 Therapy in Lynch Syndrome-associated Recurrent Glioblastoma","authors":"Wendy J. Sherman","doi":"10.33696/cancerimmunol.3.051","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.051","url":null,"abstract":"Less than 5% of glioblastomas result from a hereditary syndrome. While not common, they do occur and perhaps may be under-recognized if family history is not known. Now, with more frequent germline testing done as a component of next generation tumor sequencing, it is hypothesized that these hereditary syndromes are better detected. This improved detection is not only beneficial for screening family members and screening the patient for other associated malignancies, but this opens up an opportunity for us as clinicians and scientists to better understand the tumorigenesis of glioblastoma in hereditary syndromes, which in turn may offer individualized treatment regimens.","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46901859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profiling the Energy Metabolism at the Cell Subpopulation Level 在细胞亚群水平上分析能量代谢
Journal of cancer immunology Pub Date : 2021-11-05 DOI: 10.33696/cancerimmunol.3.050
K. Benihoud, C. Brenner
{"title":"Profiling the Energy Metabolism at the Cell Subpopulation Level","authors":"K. Benihoud, C. Brenner","doi":"10.33696/cancerimmunol.3.050","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.050","url":null,"abstract":"Although being a complex pathology with genetic as well as non-genetic etiologies, cancer is characterized by a limited series of hallmarks including energetic metabolism reprogramming [1]. Long ago O. Warburg unraveled a bias of tumor metabolism in favor of glycolysis, the socalled Warburg effect. Indeed, tumor cells display both an increase in glucose uptake and fermentation of glucose to lactate [2]. Since these pioneering works, different alterations of tumor metabolism were reported such as deregulated uptake of glutamine or new modes of nutrient acquisition [3]. In general, cancer cells exhibit a high rate of proliferation due to constitutive anabolism and catabolism activation. Moreover, by competing for nutrients, inducing hypoxia and releasing inhibitory molecules in tumor microenvironment (TME), tumors dramatically affect immune cell metabolism [4].","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44907511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycyclic Aromatic Hydrocarbons and Mammary Cancer Risk: Does Obesity Matter too? 多环芳烃与乳腺癌风险:肥胖也有关系吗?
Journal of cancer immunology Pub Date : 2021-10-27 DOI: 10.33696/cancerimmunol.3.052
Lydia Lichtiger, Janelle A. Rivera, Debashish Sahay, Rachel L. Miller
{"title":"Polycyclic Aromatic Hydrocarbons and Mammary Cancer Risk: Does Obesity Matter too?","authors":"Lydia Lichtiger, Janelle A. Rivera, Debashish Sahay, Rachel L. Miller","doi":"10.33696/cancerimmunol.3.052","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.052","url":null,"abstract":"Breast cancer risk remains incompletely explained, and higher incidence rates of breast cancer over recent times and in urban and industrialized areas suggest environmental causes. Polycyclic aromatic hydrocarbons (PAH) are ubiquitous in the environment and epidemiological and rodent studies have shown associations between exposure to PAH and breast cancer incidence as well as mammary tumorigenesis. In addition, in vitro and rodent studies have implicated alterations in estrogen receptor alpha (Erα) signaling pathways following PAH exposure in limited experimental studies. However, our understanding of these mechanisms is incomplete. Sahay et al. addressed this gap by examining the effect of PAH exposure on epigenetic and transcriptional regulation of genes in the Erα pathway in a mouse cohort exposed to aerosolized PAH at proportions measured in urban air. In addition to alterations in the Erα signaling pathway in the pregnant mice and in their offspring and grandoffspring, the investigators observed higher body weights in mice exposed to PAH compared to the control. Given that associations between mammary tissue adiposity, systemic adiposity, and breast cancer risk have been observed previously, the finding of higher body weight in the PAH exposure group raises the possibility that body weight might influence the association between PAH exposure and breast cancer risk. Along with new analyses, we discuss the possibility that body weight may modify the association between PAH exposure, mammary cellular proliferation, and mammary gland ductal hyperplasia in offspring and grandoffspring mice and future research that may be needed to delineate these associations.","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":"3 1","pages":"154 - 162"},"PeriodicalIF":0.0,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42372088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment Neuropilin 1和Neuropilin 2靶向治疗癌症的相关性
Journal of cancer immunology Pub Date : 2021-06-30 DOI: 10.33696/cancerimmunol.3.046
A. Dumond, Gilles Pagès
{"title":"Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment","authors":"A. Dumond, Gilles Pagès","doi":"10.33696/cancerimmunol.3.046","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.046","url":null,"abstract":"","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46783448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dose-dependent Effects of Vitamin C on Cancer Regulation: A Review 维生素C在癌症调节中的剂量依赖性研究进展
Journal of cancer immunology Pub Date : 2021-06-30 DOI: 10.33696/cancerimmunol.3.048
F. Hadi, T. Maqbool, Saira Aftab, Muhammad Tahir, S. Ramzan, K. Kiran, A. Malik, S. Akhtar
{"title":"Dose-dependent Effects of Vitamin C on Cancer Regulation: A Review","authors":"F. Hadi, T. Maqbool, Saira Aftab, Muhammad Tahir, S. Ramzan, K. Kiran, A. Malik, S. Akhtar","doi":"10.33696/cancerimmunol.3.048","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.048","url":null,"abstract":"Faheem Hadi1, Tahir Maqbool1, Saira Aftab1, Muhammad Tahir1, Shazia Ramzan2, Komal Kiran3, Arif Malik1, Shabana Akhtar1,4* 1Institute of Molecular Biology and Biotechnology, University of Lahore, Lahore, Pakistan 2Allama Iqbal Medical College Lahore, Lahore, Pakistan 3Services Hospital, Lahore, Pakistan 4School of Medical Sciences, University of Bradford, Bradford, UK *Correspondence should be addressed to Shabana Akhtar; s.akhtar133@bradford.ac.uk, shabana.akhtar@imbb.uol.edu.pk","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45097196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Roles of Pseudogene RNAs in Antitumor and Antiviral Immunity 假基因RNA在抗肿瘤和抗病毒免疫中的新作用
Journal of cancer immunology Pub Date : 2021-06-30 DOI: 10.33696/cancerimmunol.3.045
Yoo Jane Han, Michaela U. Gack, O. Olopade
{"title":"Emerging Roles of Pseudogene RNAs in Antitumor and Antiviral Immunity","authors":"Yoo Jane Han, Michaela U. Gack, O. Olopade","doi":"10.33696/cancerimmunol.3.045","DOIUrl":"https://doi.org/10.33696/cancerimmunol.3.045","url":null,"abstract":"Tumor immunity and immunotherapy have become increasingly important in treatment strategies for a variety of malignancies including advanced triple negative breast cancer [1,2]. Although immunotherapy has been shown to be effective, patient response rates vary significantly and only a small fraction of patients respond favorably to the treatment [3]. The efficacy of cancer immunotherapy appears to depend on the host immune system recognizing and eliminating cancer cells [4]. Increasing evidence demonstrates a positive correlation between the presence of host antitumor immune responses and favorable patient outcomes for many cancers [5-8]. As an example, tumors with a high density of tumor-infiltrating lymphoid cells (TILs) in the tumor microenvironment are more likely to respond to immune checkpoint inhibitors, whereas those with low or no TILs are less likely to respond to the inhibitors [9-11]. Thus, interventions that render nonresponding tumors to become responding tumors and hence promote antitumor immunity bear tremendous therapeutic potential.","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41779899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycyclic Aromatic Hydrocarbons and Mammary Cancer Risk: Does Obesity Matter too? 多环芳烃与乳腺癌风险:肥胖也有关系吗?
Journal of cancer immunology Pub Date : 2021-01-01
Lydia Lichtiger, Janelle Rivera, Debashish Sahay, Rachel L Miller
{"title":"Polycyclic Aromatic Hydrocarbons and Mammary Cancer Risk: Does Obesity Matter too?","authors":"Lydia Lichtiger,&nbsp;Janelle Rivera,&nbsp;Debashish Sahay,&nbsp;Rachel L Miller","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Breast cancer risk remains incompletely explained, and higher incidence rates of breast cancer over recent times and in urban and industrialized areas suggest environmental causes. Polycyclic aromatic hydrocarbons (PAH) are ubiquitous in the environment and epidemiological and rodent studies have shown associations between exposure to PAH and breast cancer incidence as well as mammary tumorigenesis. In addition, <i>in vitro</i> and rodent studies have implicated alterations in estrogen receptor alpha (<i>Erα</i>) signaling pathways following PAH exposure in limited experimental studies. However, our understanding of these mechanisms is incomplete. Sahay et al. addressed this gap by examining the effect of PAH exposure on epigenetic and transcriptional regulation of genes in the <i>Erα</i> pathway in a mouse cohort exposed to aerosolized PAH at proportions measured in urban air. In addition to alterations in the <i>Erα</i> signaling pathway in the pregnant mice and in their offspring and grandoffspring, the investigators observed higher body weights in mice exposed to PAH compared to the control. Given that associations between mammary tissue adiposity, systemic adiposity, and breast cancer risk have been observed previously, the finding of higher body weight in the PAH exposure group raises the possibility that body weight might influence the association between PAH exposure and breast cancer risk. Along with new analyses, we discuss the possibility that body weight may modify the association between PAH exposure, mammary cellular proliferation, and mammary gland ductal hyperplasia in offspring and grandoffspring mice and future research that may be needed to delineate these associations.</p>","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":" ","pages":"154-162"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39842277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy. 免疫性细胞死亡:自噬在癌症治疗中的领先一步
Journal of cancer immunology Pub Date : 2021-01-01 DOI: 10.33696/cancerimmunol.3.041
Gourab Gupta, Kristina Borglum, Hexin Chen
{"title":"Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy.","authors":"Gourab Gupta, Kristina Borglum, Hexin Chen","doi":"10.33696/cancerimmunol.3.041","DOIUrl":"10.33696/cancerimmunol.3.041","url":null,"abstract":"<p><p>Immunogenic cell death (ICD) plays a major role in providing long lasting protective antitumor immunity by the chronic exposure of damage associated molecular patterns (DAMPs) in the tumor microenvironment (TME). DAMPs are essential for attracting immunogenic cells to the TME, maturation of DCs, and proper presentation of tumor antigens to the T cells so they can kill more cancer cells. Thus for the proper release of DAMPs, a controlled mechanism of cell death is necessary. Drug induced tumor cell killing occurs by apoptosis, wherein autophagy may act as a shield protecting the tumor cells and sometimes providing multi-drug resistance to chemotherapeutics. However, autophagy is required for the release of ATP as it remains one of the key DAMPs for the induction of ICD. In this review, we discuss the intricate balance between autophagy and apoptosis and the various strategies that we can apply to make these immunologically silent processes immunogenic. There are several steps of autophagy and apoptosis that can be regulated to generate an immune response. The genes involved in the processes can be regulated by drugs or inhibitors to amplify the effects of ICD and therefore serve as potential therapeutic targets.</p>","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":"3 1","pages":"47-59"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39185136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing Sarcoma. TIM 3和凝集素9在儿童尤文氏肉瘤诊断时肿瘤标本免疫组化染色中的高表达。
Journal of cancer immunology Pub Date : 2021-01-01 DOI: 10.33696/cancerimmunol.3.053
Stephanie J Si, Gerald B Wertheim, David M Barrett
{"title":"High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing Sarcoma.","authors":"Stephanie J Si, Gerald B Wertheim, David M Barrett","doi":"10.33696/cancerimmunol.3.053","DOIUrl":"10.33696/cancerimmunol.3.053","url":null,"abstract":"<p><p>Significant progress has been made in the advancement of immune system modulation for cancer treatment in recent years. In particular, immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell therapy have demonstrated remarkable clinical benefit in relapsed/refractory cancers. However, our understanding of the immuno-oncologic landscape in pediatric solid tumors remains limited and is a barrier to continued progress. We examined the immunohistochemical expression of checkpoint receptors PD-1, TIM-3, LAG-3 and their respective ligands in various pediatric cancers at diagnosis and found high expression of TIM-3/Galectin-9 in the infiltrating cells of Ewing sarcoma. Location of checkpoint receptor/ligand expressions is important, as some staining patterns were only seen along tumor borders. Finally, peripheral T cell function varied significantly among different tumors supporting a complex relationship between the tumor microenvironment and the global immune system.</p>","PeriodicalId":73633,"journal":{"name":"Journal of cancer immunology","volume":"3 3","pages":"163-176"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9334294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书